| European association of urology guidelines on renal cell carcinoma: the 2019 update B Ljungberg, L Albiges, Y Abu-Ghanem, K Bensalah, S Dabestani, ... European urology 75 (5), 799-810, 2019 | 1376 | 2019 |
| European Association of Urology guidelines on renal cell carcinoma: the 2022 update B Ljungberg, L Albiges, Y Abu-Ghanem, J Bedke, U Capitanio, ... European urology 82 (4), 399-410, 2022 | 871 | 2022 |
| Methodology of a systematic review E Linares-Espinós, V Hernández, JL Domínguez-Escrig, ... Actas Urológicas Españolas (English Edition) 42 (8), 499-506, 2018 | 252 | 2018 |
| Metodología de una revisión sistemática E Linares-Espinós, V Hernández, JL Domínguez-Escrig, ... Actas Urológicas Españolas 42 (8), 499-506, 2018 | 215 | 2018 |
| Updated European Association of Urology guidelines on renal cell carcinoma: immune checkpoint inhibition is the new backbone in first-line treatment of metastatic clear-cell … L Albiges, T Powles, M Staehler, K Bensalah, RH Giles, M Hora, ... European urology 76 (2), 151-156, 2019 | 214 | 2019 |
| Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer T Powles, L Albiges, M Staehler, K Bensalah, S Dabestani, RH Giles, ... European urology 73 (3), 311-315, 2018 | 214 | 2018 |
| A systematic review and meta-analysis comparing the effectiveness and adverse effects of different systemic treatments for non-clear cell renal cell carcinoma S Fernandez-Pello, F Hofmann, R Tahbaz, L Marconi, TB Lam, L Albiges, ... European urology 71 (3), 426-436, 2017 | 155 | 2017 |
| Updated European Association of Urology guidelines on renal cell carcinoma: nivolumab plus cabozantinib joins immune checkpoint inhibition combination therapies for treatment … J Bedke, L Albiges, U Capitanio, RH Giles, M Hora, TB Lam, B Ljungberg, ... European urology 79 (3), 339-342, 2021 | 123 | 2021 |
| Management of sporadic renal angiomyolipomas: a systematic review of available evidence to guide recommendations from the European Association of Urology Renal Cell Carcinoma … S Fernández-Pello, M Hora, T Kuusk, R Tahbaz, S Dabestani, ... European urology oncology 3 (1), 57-72, 2020 | 109 | 2020 |
| Updated European Association of Urology guidelines for cytoreductive nephrectomy in patients with synchronous metastatic clear-cell renal cell carcinoma A Bex, L Albiges, B Ljungberg, K Bensalah, S Dabestani, RH Giles, ... European urology 74 (6), 805-809, 2018 | 101 | 2018 |
| Long-term outcomes of follow-up for initially localised clear cell renal cell carcinoma: RECUR database analysis S Dabestani, C Beisland, GD Stewart, K Bensalah, E Gudmundsson, ... European urology focus 5 (5), 857-866, 2019 | 96 | 2019 |
| European Association of Urology-American Society of Clinical Oncology collaborative guideline on penile cancer: 2023 update OR Brouwer, M Albersen, A Parnham, C Protzel, CA Pettaway, B Ayres, ... European urology 83 (6), 548-560, 2023 | 72 | 2023 |
| Limitations of available studies prevent reliable comparison between tumour ablation and partial nephrectomy for patients with localised renal masses: a systematic review from … Y Abu-Ghanem, S Fernandez-Pello, A Bex, B Ljungberg, L Albiges, ... European urology oncology 3 (4), 433-452, 2020 | 61 | 2020 |
| The impact of histological subtype on the incidence, timing, and patterns of recurrence in patients with renal cell carcinoma after surgery—results from RECUR Consortium Y Abu-Ghanem, T Powles, U Capitanio, C Beisland, P Järvinen, ... European urology oncology 4 (3), 473-482, 2021 | 40 | 2021 |
| Envejecimiento y aprendizaje a lo largo de la vida S Pinazo Hernandis, X Lorente Guerrero, MR Limón Mendizábal, ... Envejecimiento activo y actividades socioeducativas con personas mayores …, 2010 | 39 | 2010 |
| Modelo de calidad de vida aplicado a la atención residencial de personas con necesidades complejas de apoyo MA Verdugo, R Canal, S Fernández, L Bermejo, S Alonso, J Tamarit, ... Imserso. Madrid, 2011 | 37 | 2011 |
| 2021 Updated European Association of Urology guidelines on the use of adjuvant pembrolizumab for renal cell carcinoma J Bedke, L Albiges, U Capitanio, RH Giles, M Hora, TB Lam, B Ljungberg, ... European Urology 81 (2), 134-137, 2022 | 34 | 2022 |
| Very low microsatellite polymorphism and large heterozygote deficits suggest founder effects and cryptic structure in the parasite Perkinsus olseni R Vilas, A Cao, BG Pardo, S Fernández, A Villalba, P Martínez Infection, Genetics and Evolution 11 (5), 904-911, 2011 | 34 | 2011 |
| Los eventos adversos y la seguridad del paciente S Fernández Recuperado de 2, 2015 | 33 | 2015 |
| The 2022 updated european association of urology guidelines on the use of adjuvant immune checkpoint inhibitor therapy for renal cell carcinoma J Bedke, L Albiges, U Capitanio, RH Giles, M Hora, B Ljungberg, ... European urology 83 (1), 10-14, 2023 | 32 | 2023 |
